3SBio (HKSE:01530) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 25, 2025)

View and export this data going back to 2015. Start your Free Trial

What is 3SBio Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, 3SBio's float shares is 0.00 Mil. 3SBio's total shares outstanding is 2,355.22 Mil. 3SBio's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, 3SBio's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, 3SBio's Institutional Ownership is 20.91%.

3SBio Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

3SBio's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	0.00	/	2,355.22
	=	0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3SBio Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3SBio Inc (HKSE:01530) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

83B:Germany

Address

No. 3 A1, Road 10, Shenyang Economy and Technology Development Zone, Shenyang, CHN, 110027

Website

https://www.3sbio.com

3SBio Inc is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics.

Executives

Blackrock, Inc.	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Lou Jing	2305 Beneficiary of a trust
Jpmorgan Chase & Co.	2502 Approved lending agent
Hsbc Holdings Plc	2302 Custodian
Citic Securities Company Limited	2201 Interest of corporation controlled by you
Citron Pe Associates, L.p.	2201 Interest of corporation controlled by you
Citron Pe Funds Limited	2201 Interest of corporation controlled by you
Citron Pe Holdings Limited	2201 Interest of corporation controlled by you
Cpechina Fund, L.p.	2201 Interest of corporation controlled by you
Cs Sunshine Investment Limited	2101 Beneficial owner
Xing Lily
Century Sunshine Limited
Decade Sunshine Limited
Lambda International Limited

3SBio Headlines

No Headlines